Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

June 30, 2010

Conditions
Alzheimer's DiseaseApathyDementia
Interventions
DRUG

Methylphenidate

Subject will receive 5mg twice a day for two weeks then 10mg twice a day until week 12 of the study.

OTHER

Placebo

Standard inactive pill.

Trial Locations (1)

68105-1873

VA Medical Center, Omaha, Omaha

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT00495820 - Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study | Biotech Hunter | Biotech Hunter